|Articles|March 10, 2023
- Pharmaceutical Executive: March 2023
- Volume 43
- Issue 3
Pharmaceutical Executive, March 2023 Issue (PDF)
Advertisement
Articles in this issue
over 3 years ago
Navigating Disruption in the Metapharma Eraover 3 years ago
Biopharma M&A: Year in Review, Ripples Aheadover 3 years ago
Balancing Pharma Hiring Practices in Good Times and Badover 3 years ago
Being KOL-Centric: More Meaningful Expert Engagementover 3 years ago
Food for Thought: Make Room for Multiple Opinionsover 3 years ago
The Pivot to Digitalover 3 years ago
More than Ever, Data Will Dictate Future Fortunesover 3 years ago
Generative AI’s Breakthrough Potential in Pharma Marketingover 3 years ago
The Challenge of Taking on Falsified Medicines in EuropeAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection
5